Extensive memory testing improves prediction of progression to MCI in late middle age

Daniel E Gustavson1,2, Jeremy A Elman2, Mark Sanderson-Cimino2

  • 1Division of Genetic Medicine Department of Medicine Vanderbilt University Medical Center Nashville Tennessee.

Abstract

Insights

Combining multiple memory tests in middle-aged adults can predict mild cognitive impairment (MCI) risk up to six years in advance. This non-invasive approach aids early Alzheimer's disease identification before biomarkers appear.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Gerontology

Background:

  • Early Alzheimer's disease (AD) prediction is crucial when individuals are biomarker-negative.
  • Non-invasive methods for predicting cognitive decline are needed.
  • Identifying risk for mild cognitive impairment (MCI) in middle age aids early intervention.

Purpose of the Study:

  • To evaluate the predictive power of memory tests for 6-year MCI progression in cognitively normal middle-aged adults.
  • To determine if combining multiple memory tests enhances prediction accuracy.
  • To compare neuropsychological prediction with biomarker-based prediction.

Main Methods:

  • Examined 849 cognitively normal men (mean age 55.69 years).
  • Utilized the California Verbal Learning Test and other memory assessments.
  • Developed a latent factor model incorporating seven memory measures.

Main Results:

  • The California Verbal Learning Test learning trials best predicted amnestic MCI (OR=4.75).
  • A latent factor combining seven measures significantly improved prediction (OR=9.88).
  • This prediction favorably compared to biomarker-based methods in older adults.

Conclusions:

  • Neuropsychological tests effectively identify early MCI risk in middle age, preceding biomarker positivity.
  • While single tests offer some prediction, combining multiple measures substantially improves accuracy.
  • Extended testing (30 minutes) with multiple scores provides superior prediction of cognitive decline.